Nintedanib as maintenance treatment of malignant pleural mesothelioma (NEMO): a double-blind randomized phase II study of the EORTC Lung Cancer Group - NEMO

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2017
This article has no abstract
Epistemonikos ID: c11e96e0dab4a13085fb28a2de3124023f09fbd5
First added on: Apr 17, 2025